Payers cover novel cancer drugs but not the staffing, training, and monitoring to deliver them, leaving practices to absorb costs.
|Articles|April 1, 2000
Supplements and Featured Publications
- Asthma Management Alternatives for the New Millennium
- Volume 6
- Issue 7 Suppl
Introduction
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
The 1997 Asthma Guidelines and an Asthma Clinical Updateover 26 years ago
Discussion: Implementing the 1997 Asthma Guidelinesover 26 years ago
Overview of HEDIS 2000 Asthma Measurementover 26 years ago
Discussion: Using the HEDIS Asthma Measurementover 26 years ago
Discussion: The Impact of Allergens on Asthma Severity and Treatmentover 26 years ago
Adjunctive Therapy: Treatment Optionsover 26 years ago
Discussion: Treatment Options for Asthmaover 26 years ago
Pharmacoeconomic Impact of Inhaled CorticosteroidsAdvertisement
Related to this article
The 2026 COA Payer Exchange and Innovation Summit began with a panel on AI and the ever-changing digital infrastructure in community oncology.
Expert panel discussions covered AI and community access, chronic lymphocytic leukemia, myeloma, and breast and lung cancers.
Longer undetectable hepatitis D RNA on bulevirtide predicts durable suppression off therapy, but rebound and ALT flares rise, especially in cirrhosis.
Experts tackled CAR T access, trial equity, and overtreatment in breast cancer at an AJMC Institute for Value-Based Medicine event in San Francisco.
Systematic review finds combined immunonutrition (arginine, omega-3s, glutamine) in colorectal cancer surgery may cut surgical site infections, while single supplements show no benefit.
FACT Accreditation lets Tennessee Oncology bring community oncology CAR T-cell therapy closer to home, expanding access for non-Hodgkin lymphoma patients.
The analysis found a nonlinear association between systemic inflammation and overactive bladder, with stronger links at higher inflammation levels.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
2
Access and Innovation in North Carolina’s Research Triangle
3
Biomarker-Driven Care Is Racing Ahead of the Systems Built to Support It
4
Overcoming Barriers to Precision Care and Patient Access
5